Financial Results - Standalone (Quarter ended June 30, 2026)

  • Revenue from operations: ₹573.10 lakhs
  • Other income: ₹7.47 lakhs
  • Total income: ₹580.57 lakhs
  • Employee benefits expense: ₹322.22 lakhs
  • Finance costs: ₹39.72 lakhs
  • Depreciation and amortization: ₹22.29 lakhs
  • Other expenses: ₹477.47 lakhs
  • Total expenses: ₹861.70 lakhs
  • Loss before exceptional items and tax: ₹281.13 lakhs
  • Exceptional items: ₹17.13 lakhs (provision for bad and doubtful debts)
  • Loss before tax: ₹298.26 lakhs
  • Tax expense: ₹4.05 lakhs (deferred tax)
  • Net loss after tax: ₹294.21 lakhs
  • Basic and diluted EPS: (₹0.88) per share
  • Paid-up equity share capital: ₹1,670.53 lakhs (face value ₹5 each)
  • Weighted average shares: 3,34,10,605

Financial Results - Consolidated (Quarter ended June 30, 2026)

  • Revenue from operations: ₹1,351.10 lakhs
  • Other income: ₹7.50 lakhs
  • Total income: ₹1,358.60 lakhs
  • Employee benefits expense: ₹877.54 lakhs
  • Finance costs: ₹38.99 lakhs
  • Depreciation and amortization: ₹22.29 lakhs
  • Other expenses: ₹540.36 lakhs
  • Total expenses: ₹1,479.19 lakhs
  • Loss before exceptional items and tax: ₹120.59 lakhs
  • Exceptional items: ₹17.13 lakhs
  • Loss before tax: ₹137.72 lakhs
  • Tax expense: ₹30.70 lakhs (current tax ₹32.85 lakhs, deferred tax ₹2.15 lakhs)
  • Net loss after tax: ₹168.41 lakhs
  • Loss attributable to owners: ₹171.39 lakhs
  • Basic and diluted EPS: (₹0.51) per share

Going Concern Uncertainty

Auditors emphasized material uncertainty regarding going concern basis:

  • Standalone: Current liabilities exceed total assets by ₹1,551.23 lakhs as of June 30, 2026
  • Consolidated: Current liabilities exceed total assets by ₹3,251 lakhs as of June 30, 2026
  • Company facing constraints in meeting operational expenses and discharging current liabilities
  • Exposed to potential liabilities from legal and regulatory proceedings by CBDT and CBIC
  • Management identified Q2-Q4 FY27 as critical assessment period for operational and financial turnaround
  • Promoters committed to providing necessary financial support
  • If improvements not achieved, may need to prepare financial statements on liquidation basis

SEBI Regulatory Matters

1. Company paid ₹200 lakhs penalty on March 27, 2026 pursuant to SAT directions regarding SEBI order WTM/AB/CFID_3/22165/22-23 dated December 2022

2. Recognized provision of ₹42.01 lakhs for interest and recovery costs during current quarter, discharged on May 7, 2026

3. SEBI imposed ₹300 lakh penalty on Mr. Suresh Venkatachari (December 16, 2022 order) - penalty paid but interest outstanding

4. SEBI sold equity shares of promoter Mr. R.S. Ramani during quarter, reducing holding from 1.39% to 1.23%

5. SEBI order dated July 31, 2026: Prohibited Mr. Suresh Venkatachari and Mr. R.S. Ramani from securities market for 2 years and imposed ₹10 lakh penalty each

Healthcare Triangle Inc. Agreement

  • HCTI to issue 2,828,167 common shares to SecureKloud or its nominee Blockedge Technologies Inc.
  • Value approximately ₹42 crore
  • Make-whole for Series B Convertible Preferred Stock issued pursuant to Asset Transfer Agreement dated October 21, 2024
  • Considered related party transaction as Mr. Suresh Venkatachari holds super voting rights in HCTI
  • Governed by market price

Contingent Liabilities

  • Goods and Services Tax: ₹134.07 lakhs (disputed)
  • Income Tax: ₹312.59 lakhs (disputed)
  • Matters pending before various appellate authorities
  • Management believes unlikely to have material adverse impact

Other Corporate Actions

  • Board approved convening of 41st Annual General Meeting on September 25, 2026 through VC/OAVM
  • Meeting duration: 6:00 pm to 7:30 pm on August 10, 2026

Subsidiaries Included in Consolidation

1. SecureKloud Technologies Inc, USA

2. Blockedge Technologies Inc, USA

3. Healthcare Triangle Private Limited, India

4. SecureKloud Technologies Inc, Canada

5. Nexage Technologies Inc, USA

6. Mentorminds Solutions and Services Inc, USA